Viewing nowArotin Tablet 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
CTC Bio, Co., Ltd.

MFDS item code 201507737 · Approved 2015.11.17 · Insurance code 669501560
Reduction of risk for myocardial infarction and stroke, improvement of hypercholesterolemia
This medication is primarily used to reduce the risk of cardiovascular disease and to improve hyperlipidemia. It reduces the risk of myocardial infarction and stroke in adults with multiple risk factors for cardiovascular disease, particularly those with coronary heart disease and patients with type 2 diabetes, as well as lowering the risk of revascularization procedures and angina. Additionally, it provides a risk-reduction effect for nonfatal myocardial infarction, fatal and non-fatal stroke, and hospitalization due to congestive heart failure in patients already diagnosed with coronary heart disease. For hyperlipidemia, it is used to control cholesterol and other lipid levels in patients with primary and mixed dyslipidemia and can be used in combination with other treatments in some familial hypercholesterolemia patients. It is also used as an adjunct to lower LDL cholesterol levels in some pediatric patients aged 10 to 17 years. This medication is effective in improving cardiovascular health and controlling lipid levels.
For hyperlipidemia: The recommended starting dose is 10 mg of atorvastatin once daily; for patients needing more significant LDL cholesterol reduction, it may start at 20 mg or 40 mg once daily. This medication is administered once daily within a dose range of 10 to 80 mg. Initial and maintenance doses should be individualized based on therapeutic goals and responses, with lipid levels analyzed and dosage adjusted within 2–4 weeks after initiation or dose modification.
For pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17): The recommended starting dose is 10 mg once daily, with a maximum recommended dose of 20 mg once daily. The dosage may be adjusted according to therapeutic goals.
This medication may cause muscle abnormalities; therefore, it should be discontinued immediately if muscle pain or weakness worsens or if creatine kinase levels rise significantly. This medication should not be used in patients with specific diseases or conditions, such as liver disease, muscle disorders, pregnant or breastfeeding women, children under 10 years of age, and patients taking certain medications. Patients with liver or kidney dysfunction should be particularly cautious when using this medication and should have regular liver function and muscle-related tests. During treatment, if symptoms such as muscle pain, fatigue, or fever occur, patients must inform healthcare professionals immediately, and blood tests may be done to check the condition. Moreover, this medication can interact with several other drugs, so it is essential to inform healthcare professionals if taking other medications, particularly with certain antibiotics, antifungals, and HIV treatments. Pregnant women or those who could become pregnant should not use this medication and should employ appropriate contraception during treatment. Breastfeeding women should also avoid taking this medication, and children or the elderly should use it cautiously due to a higher risk of side effects. As there is no specific antidote for overdose, treatment should be symptomatic, and liver function and muscle status should be monitored periodically. This medication should be stored out of reach of children and in its original container for safety.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, skin peeling, pain of oral/ocular mucosa, shortness of breath or breathing difficulties, asthma attack, respiratory distress accompanied by cough and fever, jaundice (yellowing of skin or eyes), extreme drowsiness, sudden and severe headaches, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination issues.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture entry. It should also be kept in a place that avoids extremes of temperature, ideally between 1 to 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
CTC Bio, Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.